SZNH(SH:600736) 智通财经网·2025-11-25 10:06Core Viewpoint - Suzhou Gaoxin plans to sell a 47% stake in Suzhou Medical Device Industry Development Group to Suzhou High-tech Zone State-owned Capital Holding Group for 604 million yuan, aiming to enhance overall profitability and reduce the impact on financial statements [1] Group 1: Transaction Details - The transaction involves the sale of 47% equity in the medical device subsidiary for a price of 604 million yuan [1] - The sale is intended to align with the interests of the company and all shareholders [1] Group 2: Company Performance - Since the acquisition of the medical device subsidiary, the scale of the Jiangsu Medical Device Technology Industrial Park has continued to expand [1] - The increase in investment property amortization has been noted, alongside underperformance in the subsidiary's operating results due to cyclical impacts from the medical device industry and capital markets [1]